SUSAN LOGSDON: Open Payments
NPI 1578645958 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 24 payments from 8 companies in 2025. Trend: 2023 $645 · 2024 $298 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $96 |
| Astellas Pharma US Inc | 3 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $51 |
| MILLICENT US INC | 2 | $37 |
| CooperSurgical, Inc. | 1 | $19 |
| Organon LLC | 2 | $18 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: ZURZUVAE, Veozah, Mirena, FEMLYV, Lynkuet, Paragard T 380A, NEXPLANON, INTRAROSA.
Industry payments across IN — which companies pay providers there.
